Loncar Cancer Immunotherapy ETF (CNCR): Price and Financial Metrics ETF
CNCR Price/Volume Stats - 7 Best ETFs for the NEXT Bull Market
| Current price | $14.39 | 52-week high | $17.96 |
| Prev. close | $13.95 | 52-week low | $9.22 |
| Day low | $13.94 | Volume | 3,200 |
| Day high | $14.43 | Avg. volume | 30,784 |
| 50-day MA | $15.98 | Dividend yield | N/A |
| 200-day MA | $13.04 |
CNCR Stock Price Chart Interactive Chart >
Loncar Cancer Immunotherapy ETF (CNCR) ETF Bio
The investment objective of the Loncar Cancer Immunotherapy ETF seeks to replicate the Loncar Cancer Immunotherapy Index. The index was developed by a top biologist and includes large pharmaceutical and growth-oriented biotechnology firms that are focused on improving cancer treatments.
CNCR ETF Info
| Issuer | Range ETFs |
| Expense Ratio | 0.79% |
| Underlying Index | Range Cancer Therapeutics Index |
| Asset Class | Equity |
| Sector | Health & Biotech ETFs |
| Assets Under Management (AUM) | 17.70M |
| Net Asset Value (NAV) | $14.39 |
| Options? | Yes |
| Total Holdings | N/A |
CNCR Top Holdings
| Symbol | Company | % of Total |
CNCR Price Returns
| 1-mo | -12.52% |
| 3-mo | 2.86% |
| 6-mo | 55.74% |
| 1-year | 15.40% |
| 3-year | -50.14% |
| 5-year | -23.97% |
| YTD | 6.83% |
| 2023 | -1.89% |
| 2022 | -42.31% |
| 2021 | -19.24% |
| 2020 | 36.53% |
| 2019 | 24.22% |